Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imine Reductase Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116286700B reveals enhanced imine reductase mutants for nicotine synthesis offering superior yield and supply chain reliability for global pharmaceutical manufacturers.
Patent CN115948360A details an imine reductase mutant achieving >99.5% conversion and 99.6% ee for nicotine analog intermediates, offering significant cost and supply chain advantages.